A NSW Government website

On

Clinical Immunology Research

The Clinical Immunology and Allergy Department at RPA has an extensive research program across several areas including basic immunology sciences, autoimmune diseases, and designing novel assays for diagnosis of immune-mediated disorders. 

In 2024 we established a biobanking repository for serum and cells from patients with autoimmune and inflammatory diseases to assist in our future studies. The department at Royal Prince Alfred, in conjunction its sister department at Concord Hospital, have established the Sydney Translational Immunology and Allergy Centre and this has been recognised as an international Centre of Excellence of the Federation of Clinical Immunology Societies (FOCiS).

Selected Grants

Amount awarded Grant and project details
$2,752,967 MRFF, 2023-2025
Comparing Immunisation-boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies (CIRCUIT Study).
Investigators: Lee FJ
$135,000 NHMRC, 2023-2025
Postgraduate Research Scholarship.
Investigator: Stoyanov A
$995,867 NSW Health COVID-19 Vaccine Acceleration Research Grant, 2023-2024
Nasal delivered COVID vaccine to block transmission of SARS-CoV-2.
Investigators: Britton WJ, Ashhurst A, Johansen M, Payne RP, Young P, Hansbro P Triccas JA. Steain N, Byrne S, Turville S.
$352,879 NSW Dust Diseases Board, 2023-2024
Defining new and effective therapies against the pathogenesis of accelerated silicosis.
Investigators: Hansbro P, Britton WJ, Chambers D, Quan D, Troy L, Corte T, Hansbro N, Gang L.
US$13,100,000 NIH, 2022-2027
Advancing Vaccine Adjuvant Research for Tuberculosis Contract.
Investigators: Britton WJ, Izzo A, Triccas JA
€200,023 Leprosy Research Initiative (Holland), 2022-2025
The COMBINE study: Defining the impact of combined community-wide screening and mass chemoprophylaxis for leprosy in Kiribati: a prospective community implementation study.
Investigators: Chambers S, Britton WJ, Tomlinson J, Marais B, Marks GB, Priest P, Ioteba N, Maribo, Cunanan A, Hill J, Coleman M.
$896,784 NHMRC Ideas Grant, 2022-2024
Defining the impact of chronic lung disease on COVID-19 and developing effective therapies
Investigators: Britton WJ, Hansbro N, Johansen M, Idrees S.
$4,248,555 MRFF, 2020-2024
Pathway to the Elimination of Antibiotic-Resistant and Latent Tuberculosis in the Pacific: the PEARL study
Investigators: Marais B, Britton WJ, Marks GB, Fox G, Saunders BM, Trauer J, Viney K

Our Publications

2024

Heynemann S, Vanguru V, Adelstein S, Kao S. Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy. Asia Pac J Clin Oncol. 2024 Apr;20(2):315-318. doi: 10.1111/ajco.13906. Epub 2022 Dec 23.
Bosi I, Singh-Grewal D. Child with swollen fingers associated with recent SARS-CoV-2 infection. J Paediatr Child Health. 2024 Jan;60(1):32-33. doi: 10.1111/jpc.16350. Epub 2023 Jan 31. 
Sutton KM, Wiggins M, Zaragoza R, Swamy S. Chronic spontaneous urticaria as the presenting feature in a paediatric case of chronic myeloid leukaemia. Pediatr Blood Cancer. 2024 Mar;71(3):e30846. doi: 10.1002/pbc.30846. Epub 2024 Jan 7. 
Wright K, Han DJ, Song R, de Silva K, Plain KM, Purdie AC, Shepherd A, Chin M, Hortle E, Wong JJ, Britton WJ, Oehlers SH. Zebrafish tsc1 and cxcl12a increase susceptibility to mycobacterial infection. Life Sci Alliance. 2024 Feb 2;7(4):e202302523. doi: 10.26508/lsa.202302523. 
Marinelli T, Masters J, Buckland ME, Lee M, Rawlinson W, Kim KW, Urriola N, van Hal S. Chronic and Neurotropic: A Paradigm-Challenging Case of Dengue Virus Encephalitis in a Patient With Advanced HIV Infection. Clin Infect Dis. 2024 Aug 16;79(2):498-501. doi: 10.1093/cid/ciae061. 
Chu GJ, Bailey CG, Nagarajah R, Liang O, Metierre C, Sagnella SM, Castelletti L, Yeo D, Adelstein S, Rasko JEJ. Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity. Cytotherapy. 2024 Apr;26(4):325-333. doi: 10.1016/j.jcyt.2024.01.011. Epub 2024 Feb 13. 
Stewart EL, Counoupas C, Quan DH, Wang T, Petrovsky N, Britton WJ, Triccas JA. Lung IL-17A-Producing CD4+ T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines. Vaccines (Basel). 2024 Jan 26;12(2):128. doi: 10.3390/vaccines12020128.
Bosi I, Ford LS. Erythritol allergy. J Paediatr Child Health. 2024 Jun;60(6):248-249. doi: 10.1111/jpc.16565. Epub 2024 May 13.
Stewart EL, Counoupas C, Steain M, Ashley C, Alca S, Hartley-Tassell L, von Itzstein M, Britton WJ, Petrovsky N, Triccas JA. Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) is a cellular receptor for delta inulin adjuvant. Immunol Cell Biol. 2024 Aug;102(7):593-604. doi: 10.1111/imcb.12774. Epub 2024 May 17. 
Goh DSL, Yuson R, Gounder P, Yun J, Limaye S. Strategic testing following toxic epidermal necrolysis allows reintroduction of chemotherapy in a patient with progressive myeloma. Asia Pac Allergy. 2024 Jun;14(2):90-92. doi: 10.5415/apallergy.0000000000000125. Epub 2023 Dec 18. 
Lee E, Bosi I, Peacock K, Lau C, Ford LS, Wong M, Hsu P. Novel infantile presentations of chronic granulomatous disease. Pediatr Allergy Immunol. 2024 Jul;35(7):e14190. doi: 10.1111/pai.14190.
Bradhurst P, Stoyanov A, Nithichanon A, Bundell C, Urriola N. A homogeneous bioluminescent inhibition immunoassay to detect anti-interferon gamma antibodies. Clin Exp Immunol. 2024 Nov 12;218(3):283-290. doi: 10.1093/cei/uxae055. 
King JM, Giallonardo FD, Shaik A, McGregor S, Yeung JYK, Sivaruban T, Lee FJ, Cunningham P, Dwyer DE, Nigro SJ, Grulich AE, Kelleher AD. Low HIV drug resistance prevalence among recently diagnosed HIV-positive men who have sex with men in a setting of high PrEP use. J Int AIDS Soc. 2024 Jul;27(7):e26308. doi: 10.1002/jia2.26308. 
Maxwell JWC, Stockdale S, Stewart EL, Ashley CL, Smith LJ, Steain M, Triccas JA, Byrne SN, Britton WJ, Ashhurst AS, Payne RJ. Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2. ACS Infect Dis. 2024 Sep 13;10(9):3419-3429. doi: 10.1021/acsinfecdis.4c00544. Epub 2024 Aug 28. 
Sprogyte L, Park M, Nureen L, Tedla N, Richardson A, Di Girolamo N. Development and characterization of a preclinical mouse model of alkali-induced limbal stem cell deficiency. Ocul Surf. 2024 Oct;34:329-340. doi: 10.1016/j.jtos.2024.08.015. Epub 2024 Aug 29.
Torres-Robles A, Baysari M, Allison K, Shaw M, Hutchings O, Britton WJ, Wilson A, Poon SK. Assessment of health technology acceptability for remote monitoring of patients with COVID-19: A measurement model for user perceptions of pulse oximeters. Digit Health. 2024 Sep 11;10:20552076241269513. doi: 10.1177/20552076241269513. 
Nisa A, Pinto R, Britton WJ, Triccas JA, Counoupas C. Immunogenicity and Protective Efficacy of a Multi-Antigen <i>Mycobacterium tuberculosis</i> Subunit Vaccine in Mice. Vaccines (Basel). 2024 Aug 30;12(9):997. doi: 10.3390/vaccines12090997. 
Quan DH, Wang T, Martinez E, Kim HY, Sintchenko V, Britton WJ, Triccas JA, Alffenaar JC. Synergistic oral beta-lactam combinations for treating tuberculosis. J Appl Microbiol. 2024 Oct 3;135(10):lxae255. doi: 10.1093/jambio/lxae255. 
Shrestha LB, Tungatt K, Aggarwal A, Stubis A, Fewings NL, Fichter C, Akerman A, Rodrigo C, Tedla N, Lee S, Lloyd AR, Brilot F, Britton WJ, Kelleher A, Caterson ID, Douglas MW, Rockett R, Tangye SG, Triccas JA, Turville SG, Sandgren KJ, Bull RA, Cunningham AL; VIIM Collaborative Research Group of NSW. Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variants. EBioMedicine. 2024 Dec;110:105461. doi: 10.1016/j.ebiom.2024.105461. Epub 2024 Nov 28. 
Bedding MJ, Forster BC, Giltrap AM, Stevens MT, Corcilius L, Britton WJ, Payne RJ. Modular Total Synthesis and Antimycobacterial Activity of Rufomycins. Org Lett. 2024 Dec 20;26(50):10993-10998. doi: 10.1021/acs.orglett.4c04163. Epub 2024 Dec 9.